Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Milbar Laboratories, Inc.
FDA Inspection
•Milbar Laboratories, Inc.•November 7, 2024

Milbar Laboratories, Inc. – FDA Inspection, Nov 7, 2024

Record Details

This FDA Inspection record concerns Milbar Laboratories, Inc., with an inspection on November 7, 2024, issued by the New England District Office, covering human drugs.

Company
Milbar Laboratories, Inc.
Inspection Date
November 7, 2024
Product Type
Human Drugs
Office
New England District Office
People
  • Anne P. Reid (FDA Associated Person)
  • Daniel B. Sweitzer
  • Daniel L. Zheng (FDA Associated Person)
  • Edwin C. Phifer (Other)
  • Samir C. Gala (FDA Associated Person)
View Company Profile

ID · 39e24588-bd00-4fd0-a7d9-b6b063552ab4

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number
1253807
FDA center
Human Drugs
Project area
Drug Quality Assurance
Outcome
Form 483 issued, view the record

FDA Citations

7
  1. 21 CFR 211.166(a)Results not used for expiration dates, storage cond.
  2. 21 CFR 211.166(a)Written program not followed
  3. 21 CFR 211.22(c)Approve or reject procedures or specs
  4. 21 CFR 211.42(a)Buildings of Suitable Size, Construction, Location
  5. 21 CFR 211.63Equipment Design, Size and Location
  6. 21 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
  7. 21 CFR 211.84(d)(2)Reports of Analysis (Components)

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Milbar Laboratories, Inc.

7
DateClassificationOfficeProject area
January 2, 2024NAICenter for Food Safety and Applied NutritionColors and Cosmetics Technology
September 27, 2022OAICenter for Drug Evaluation and ResearchDrug Quality Assurance
October 11, 2019OAICenter for Drug Evaluation and ResearchDrug Quality Assurance
December 27, 2017OAICenter for Drug Evaluation and ResearchDrug Quality Assurance
May 17, 2016VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
View all 7 other inspections on the company page
Other documents for Milbar Laboratories, Inc.
  • FDA Inspection 1231023 - 2024-01-02
  • FDA Inspection 1180954 - 2022-09-27
  • FDA Inspection 1107471 - 2019-10-11
  • FDA Inspection 1036724 - 2017-12-27
  • FDA Inspection 971848 - 2016-05-17

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Milbar Laboratories, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.